Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
Super Search
510(k) | Registration & Listing | Adverse Events | PMA | Classification | CLIA
CFR Title 21 | Advisory Committees | Assembler | Recalls | Guidance | Standards
 

New Search
Help | More About 21CFR

TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES

SUBCHAPTER D--DRUGS FOR HUMAN USE
 
PART 358MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
 

Subpart A [Reserved]

Subpart B--Wart Remover Drug Products
   § 358.101 - Scope.
   § 358.103 - Definitions.
   § 358.110 - Wart remover active ingredients.
   § 358.150 - Labeling of wart remover drug products.

Subpart C [Reserved]

Subpart D--Ingrown Toenail Relief Drug Products
   § 358.301 - Scope.
   § 358.303 - Definitions.
   § 358.310 - Ingrown toenail relief active ingredient.
   § 358.350 - Labeling of ingrown toenail relief drug products.

Subpart E [Reserved]

Subpart F--Corn and Callus Remover Drug Products
   § 358.501 - Scope.
   § 358.503 - Definitions.
   § 358.510 - Corn and callus remover active ingredients.
   § 358.550 - Labeling of corn and callus remover drug products.

Subpart G--Pediculicide Drug Products
   § 358.601 - Scope.
   § 358.603 - Definition.
   § 358.610 - Pediculicide active ingredients.
   § 358.650 - Labeling of pediculicide drug products.

Subpart H--Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis
   § 358.701 - Scope.
   § 358.703 - Definitions.
   § 358.710 - Active ingredients for the control of dandruff, seborrheic dermatitis, or psoriasis.
   § 358.720 - Permitted combinations of active ingredients.
   § 358.750 - Labeling of drug products for the control of dandruff, seborrheic dermatitis, or psoriasis.
   § 358.760 - Labeling of permitted combinations of active ingredients for the control of dandruff.

Authority: 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.
Source: 55 FR 33255, Aug. 14, 1990, unless otherwise noted.

Database Updated April 1, 2008

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH